Navigation Links
Bronchitol Cystic Fibrosis Dose Trial Results Positive
Date:8/11/2008

more, baseline FEV1 of between 40%

and 80% of the predicted normal value or a

decline in FEV1 of 20% or more in the last 12

months for those >80% predicted

Study population Median age: 16 yrs, mean FEV1: 63% predicted

Trial Location Canada and Argentina

Commercial partners None

Primary end points:

Change in FEV1 8.6% increase (139 mls) on 400 mg Bronchitol.

-1.6% on 40 mg (p=0.0006). 4.6% on 240 mg,

3.7% on 120 mg

Change in FVC 7.9% increase in FVC on 400 mg vs -0.6% on 40 mg

(p=0.0004). 3.9% on 240 mg, 1.5% on 120 mg

Secondary end points:

Other lung function 11.9% increase in MMEF on 400 mg (vs -0.3% on 40

measures; mg, change did not reach significance)

CF Questionnaire Improved 6.3 points on 400 mg vs -0.2 on 40 mg

Safety/adverse events No serious adverse events on 400 mg Bronchitol

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We cannot guarantee that any product candidate will receive FDA or other regulatory approval or th
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaxis Long-Term Safety Study of Bronchitol Completes
2. Pharmaxis Establishes Named Patient Program for Bronchitol
3. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
4. Promising Cystic Fibrosis Compound on Track for Development
5. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
6. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
7. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
8. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
9. Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
10. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
11. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014   Lincor Inc. ... experience technology to New Jersey ... agreement, CarePoint Health will deploy Lincor,s PatientLINC technology ... Christ Hospital and Hoboken University Medical Center. ... of software solutions to help hospitals reach new ...
(Date:8/19/2014)... 19, 2014 Minimally Invasive Devices Inc. (MID), ... company, announced today that Mitsubishi Corporation has formally agreed ... system in Japan . MID anticipates ... Japan in the second half of ... distributor for Karl Storz GMBH & Co. (endoscopic instruments ...
(Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2
... LLC (Berg) and GNS Healthcare, Inc. (GNS), a subsidiary ... into a joint venture named MAP Biosystems, LLC (MAP) ... critical biomedical research.  MAP will utilize a combination of ... and GNS,s patented supercomputer-driven REFS™ modeling and ...
... March 2, 2011 Accumetrics, Inc., a privately-held developer ... and easy-to-use point-of-care diagnostic system for measuring platelet reactivity ... has signed an agreement with Portola Pharmaceuticals, Inc. to ... use in clinical trials. The VerifyNow System ...
Cached Medicine Technology:Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 2Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 3Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
(Date:8/20/2014)... The finalists are in for the ... trade magazine, will honor the pharmaceutical industry’s most influential ... to outstanding companies, marketers and brand managers representing the ... are proud to announce that we received our biggest ... the number of submissions we received last year,” says ...
(Date:8/20/2014)... 2014 Little Green Pouch today announced ... Green Pouch —to meet growing demand for eco-friendly products ... homemade foods. , “The Real Food movement is ... Crawford. She continues, “Parents want to choose exactly ... things like pesticides and hidden ingredients in commercially prepared ...
(Date:8/20/2014)... 20, 2014 One Call Alert expands its ... of ResCube, a fully-mobile wearable device that connects customers to ... button, 24 hours a day, 365 days a year. , ... cross country. It operates on the T-Mobile nationwide network like ... in to work. , Like with the other One Call ...
(Date:8/20/2014)... Pittsburgh, PA (PRWEB) August 20, 2014 ... to clean the mouth in an optimal manner without ... an inventor from Vacaville, Calif. , The patent-pending DR. ... the tongue and teeth thoroughly. It promotes good oral ... to use two different devices. Convenient, compact, affordable, eco-friendly ...
(Date:8/20/2014)... the car at home and getting to work by walking, ... new study indicates. Researchers looked at thousands of people ... men and 72 percent of women drove to work, 10 ... transit, and 14 percent of men and 17 percent of ... weighed more and had higher levels of body fat than ...
Breaking Medicine News(10 mins):Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:Little Green Pouch Launches New Product to Help Health-conscious Parents Reduce Babies’ Eco-footprint 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3Health News:Want to Stay Slim? Leave the Car at Home 2
... have successfully transplanted the heart of a brain- dead ... whom Chinese traditionally do not consider dead. // ... from a brain-dead patient, the surgery is of great ... of Organ Transplantation of Tongji Hospital under Huazhong University ...
... replacing the traditional paan in Pakistan, its growing import from ... says a media report. ,In Karachi alone, 45,000 kg ... daily. ,The government has permitted imports because ... it is registered as an important import item from countries ...
... occurring infections in children and the onset of Type I ... below the age of 29, with Type 1 diabetes were ... had a number of childhood infections showed a 6 to ... O'Neill, director of care and policy at Diabetes UK, said ...
... University of Bristol have recommended that knee cartilage injuries ... any signs of osteoarthritis progression. ,'The ... only about 12 months and this is the first ... ,The study, 'Maturation of tissue engineered cartilage implanted ...
... warn that thunderstorms resulting from Britain's heatwave could trigger ... long time complaints of asthma sufferers who have claimed ... has revealed that storms sweep up and collect atmospheric ... concentrated in the air close to the ground. ...
... a study published in the Journal of the National ... suffer from premature menopause//. ,Ovarian irradiation and ... most common risk factors associated with early menopausal symptoms. ... with cancer will survive long-term. Survivors have an increased ...
Cached Medicine News:Health News:Engineered Tissue Implants benefited Knee Injured patients 2Health News:Doctors Predict an Asthma Epidemic Triggered by Thunderstorms 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: